Should You Forget Palantir and Buy These 2 Under-the-Radar AI Stocks Instead?
Palantir Technologies (PLTR 3.05%) has been one of the most impressive growth stories in the market over the past few […]
Palantir Technologies (PLTR 3.05%) has been one of the most impressive growth stories in the market over the past few […]
The Iran conflict has thrown both the U.S. economic outlook and Fed policy plans out the window. While geopolitical events
A “hidden gem” in its investment portfolio helped save the company from having an even worse year. There were numerous
Key Takeaways Fed moves aside, the biggest banks still pay nearly 0% on savings, while many smaller banks pay rates
There’s a growing number of people rethinking retirement, not because of Social Security changes or longer lifespans, but because of
In 2025, Rite Aid closed all its locations as part of a greater trend of pharmacy closures. “About a third
Instead of buying this out-of-favor space stock, stick with one of the sector’s top performers instead. For the most part,
Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.
As of this writing, Dec. 9, the Fed has begun its December meeting and will announce the policy decision tomorrow.
These high-yielding mortgage REITs go head-to-head. AGNC Investment (AGNC +2.08%) currently offers a big-time income stream. The real estate investment